These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30237123)

  • 1. Piperidinyl-embeded chalcones possessing anti PI3Kδ inhibitory properties exhibit anti-atopic properties in preclinical models.
    Dumontet C; Beck G; Gardebien F; Haudecoeur R; Mathé D; Matera EL; Tourette A; Mattei E; Esmenjaud J; Boyère C; Nurisso A; Peuchmaur M; Pérès B; Bouchaud G; Magnan A; Monneret G; Boumendjel A
    Eur J Med Chem; 2018 Oct; 158():405-413. PubMed ID: 30237123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a natural PI3Kδ inhibitor through virtual screening and biological assay study.
    Guo JF; Ning ZQ; Wu X; Qiao YJ; Wang X
    Biochem Biophys Res Commun; 2019 Jan; 508(3):709-714. PubMed ID: 30528237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of 7-(3-(piperazin-1-yl)phenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine derivatives as highly potent and selective PI3Kδ inhibitors.
    Qin LY; Ruan Z; Cherney RJ; Dhar TGM; Neels J; Weigelt CA; Sack JS; Srivastava AS; Cornelius LAM; Tino JA; Stefanski K; Gu X; Xie J; Susulic V; Yang X; Yarde-Chinn M; Skala S; Bosnius R; Goldstein C; Davies P; Ruepp S; Salter-Cid L; Bhide RS; Poss MA
    Bioorg Med Chem Lett; 2017 Feb; 27(4):855-861. PubMed ID: 28108251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb.
    Wigginton SJ; Furtado PB; Armour KL; Clark MR; Robins A; Emara M; Ghaemmaghami AM; Sewell HF; Shakib F
    Clin Exp Allergy; 2008 Feb; 38(2):313-9. PubMed ID: 18070161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and SAR of pyrrolo[2,1-f][1,2,4]triazin-4-amines as potent and selective PI3Kδ inhibitors.
    Bhide RS; Neels J; Qin LY; Ruan Z; Stachura S; Weigelt C; Sack JS; Stefanski K; Gu X; Xie JH; Goldstine CB; Skala S; Pedicord DL; Ruepp S; Dhar TG; Carter PH; Salter-Cid LM; Poss MA; Davies P
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4256-60. PubMed ID: 27476421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient targeting of phosphoinositide 3-kinase acts as a roadblock in mast cells' route to allergy.
    Collmann E; Bohnacker T; Marone R; Dawson J; Rehberg M; Stringer R; Krombach F; Burkhart C; Hirsch E; Hollingworth GJ; Thomas M; Wymann MP
    J Allergy Clin Immunol; 2013 Oct; 132(4):959-68. PubMed ID: 23683463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of highly potent and selective PI3Kδ inhibitors.
    Marcoux D; Qin LY; Ruan Z; Shi Q; Ruan Q; Weigelt C; Qiu H; Schieven G; Hynes J; Bhide R; Poss M; Tino J
    Bioorg Med Chem Lett; 2017 Jul; 27(13):2849-2853. PubMed ID: 28209465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent and highly selective benzimidazole inhibitors of PI3-kinase delta.
    Murray JM; Sweeney ZK; Chan BK; Balazs M; Bradley E; Castanedo G; Chabot C; Chantry D; Flagella M; Goldstein DM; Kondru R; Lesnick J; Li J; Lucas MC; Nonomiya J; Pang J; Price S; Salphati L; Safina B; Savy PP; Seward EM; Ultsch M; Sutherlin DP
    J Med Chem; 2012 Sep; 55(17):7686-95. PubMed ID: 22877085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Licochalcones suppress degranulation by decreasing the intracellular Ca2+ level and tyrosine phosphorylation of ERK in RBL-2H3 cells.
    Tanifuji S; Aizu-Yokota E; Funakoshi-Tago M; Sonoda Y; Inoue H; Kasahara T
    Int Immunopharmacol; 2010 Jul; 10(7):769-76. PubMed ID: 20399908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous inhibition of Vps34 kinase would enhance PI3Kδ inhibitor cytotoxicity in the B-cell malignancies.
    Liu X; Wang A; Liang X; Liu J; Zou F; Chen C; Zhao Z; Deng Y; Wu H; Qi Z; Wang B; Wang L; Liu F; Xu Y; Wang W; Fernandes SM; Stone RM; Galinsky IA; Brown JR; Loh T; Griffin JD; Zhang S; Weisberg EL; Zhang X; Liu J; Liu Q
    Oncotarget; 2016 Aug; 7(33):53515-53525. PubMed ID: 27447747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,6-O,O-Diacetylbritannilactone suppresses activation of mast cell and airway hyper-responsiveness.
    Jin M; Kim S; Qin N; Chen X; Ji N; Tang SA; Kong D; Lee E; Duan H
    Immunopharmacol Immunotoxicol; 2017 Aug; 39(4):173-179. PubMed ID: 28447503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis.
    Coffey G; DeGuzman F; Inagaki M; Pak Y; Delaney SM; Ives D; Betz A; Jia ZJ; Pandey A; Baker D; Hollenbach SJ; Phillips DR; Sinha U
    J Pharmacol Exp Ther; 2012 Feb; 340(2):350-9. PubMed ID: 22040680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of PI3Kδ reduces kidney infiltration by macrophages and ameliorates systemic lupus in the mouse.
    Suárez-Fueyo A; Rojas JM; Cariaga AE; García E; Steiner BH; Barber DF; Puri KD; Carrera AC
    J Immunol; 2014 Jul; 193(2):544-54. PubMed ID: 24935930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of basophils in allergic disease.
    Knol EF; Mul FP; Lie WJ; Verhoeven AJ; Roos D
    Eur Respir J Suppl; 1996 Aug; 22():126s-131s. PubMed ID: 8871057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and biological evaluation of novel pyrazolopyridine derivatives as potent and orally available PI3Kδ inhibitors.
    Hamajima T; Takahashi F; Kato K; Mukoyoshi K; Yoshihara K; Yamaki S; Sugano Y; Moritomo A; Yamagami K; Yokoo K; Fukahori H
    Bioorg Med Chem; 2018 May; 26(9):2410-2419. PubMed ID: 29631787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI 3-kinase and MEK kinase inhibitors differentially affect IgE-dependent and IgE-independent basophil mediator release.
    Gibbs BF; Grabbe J
    Inflamm Res; 2001 Apr; 50 Suppl 2():S53-4. PubMed ID: 11411601
    [No Abstract]   [Full Text] [Related]  

  • 17. Polymyxin B-induced basophil degranulation in atopic and non-atopic asthmatic patients.
    Górski P
    Allergol Immunopathol (Madr); 1985; 13(5):379-82. PubMed ID: 2417470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seletalisib: Characterization of a Novel, Potent, and Selective Inhibitor of PI3K
    Allen RA; Brookings DC; Powell MJ; Delgado J; Shuttleworth LK; Merriman M; Fahy IJ; Tewari R; Silva JP; Healy LJ; Davies GCG; Twomey B; Cutler RM; Kotian A; Crosby A; McCluskey G; Watt GF; Payne A
    J Pharmacol Exp Ther; 2017 Jun; 361(3):429-440. PubMed ID: 28442583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting phosphoinositide 3-kinase δ for allergic asthma.
    Rowan WC; Smith JL; Affleck K; Amour A
    Biochem Soc Trans; 2012 Feb; 40(1):240-5. PubMed ID: 22260698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of (S)-2-amino-N-(5-(6-chloro-5-(3-methylphenylsulfonamido)pyridin-3-yl)-4-methylthiazol-2-yl)-3-methylbutanamide (CHMFL-PI3KD-317) as a potent and selective phosphoinositide 3-kinase delta (PI3Kδ) inhibitor.
    Liang X; Li F; Chen C; Jiang Z; Wang A; Liu X; Ge J; Hu Z; Yu K; Wang W; Zou F; Liu Q; Wang B; Wang L; Zhang S; Wang Y; Liu Q; Liu J
    Eur J Med Chem; 2018 Aug; 156():831-846. PubMed ID: 30053721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.